Tech Company Financing Transactions
OptMed Funding Round
On 4/29/2011, OptMed raised $6 million in funding from private investors.
Transaction Overview
Company Name
Announced On
4/29/2011
Transaction Type
Venture Equity
Amount
$6,009,950
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
745 5th Ave. 500
New York, NY 10151
USA
New York, NY 10151
USA
Phone
Website
Email Address
Overview
Our lead biosurgical product in development--Devakor, a topical skin adhesive--is a replacement for surgical sutures. OptMed's therapeutics in development are based on proprietary new indications for a widely used drug to provide targeted relaxation of smooth muscle in the lower urinary tract.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Martin Sands
Chairman
Steven Sands
Chief Executive Officer
Ervin Braun
Chief Operating Officer
Alain Klapholz
Browse more venture capital transactions:
Prev: 4/29/2011: XLumena venture capital transaction
Next: 4/29/2011: Current Motor Company venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs